Literature DB >> 18255176

QT interval prolongation, torsade de pointes and renal disease.

Salvatore Patanè, Filippo Marte, Gianluca Di Bella, Alessio Currò, Sebastiano Coglitore.   

Abstract

Torsade de pointes is a form of polymorphic ventricular tachycardia occurring in a setting of prolonged QT interval on surface electrocardiogram. Several non-antiarrhythmic drugs including antibiotic and antipsychotic agents have been shown to prolong cardiac repolarization predisposing to torsade de pointes ventricular tachycardia. Blockade of the delayed rectifier (repolarising) potassium current and drug interactions with inhibitors of the cytochromes P450 (CYP)-mediated metabolism are the most common underlying mechanisms. Many antiarrhythmic drugs have been also implicated in prolonging QT interval and triggering torsades de pointes, especially during chronic therapy or in case of acute high dose toxicity. Progressive renal disease is associated from the earliest stages with increased QT interval and dispersal and with an increased risk of cardiovascular death, specifically sudden death. It has also been reported that cCorrected QT (QTc) interval prolongation and torsade de pointes are associated with end-stage renal disease (ESRD) and that they can be a cause of sudden death in ESRD. We present a case of torsade de pointes in a 82-year-old Italian woman with chronic renal failure.

Entities:  

Mesh:

Year:  2008        PMID: 18255176     DOI: 10.1016/j.ijcard.2007.11.070

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Sudden cardiac death in chronic kidney disease: epidemiology and prevention.

Authors:  M Khaled Shamseddin; Patrick S Parfrey
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

2.  Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.

Authors:  David Niedrig; Sarah Maechler; Liesa Hoppe; Natascia Corti; Helen Kovari; Stefan Russmann
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

Review 3.  Laboratory markers of ventricular arrhythmia risk in renal failure.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

Review 4.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  Torsade de pointes: A nested case-control study in an integrated healthcare delivery system.

Authors:  Neha Mantri; Meng Lu; Jonathan G Zaroff; Neil Risch; Thomas Hoffmann; Akinyemi Oni-Orisan; Catherine Lee; Carlos Iribarren
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-09-21       Impact factor: 1.468

6.  Effects of cinacalcet treatment on QT interval in hemodialysis patients.

Authors:  Gökhan Temiz; Ahmet Uğur Yalçın; Rüya Mutluay; İlter Bozacı; Cengiz Bal
Journal:  Anatol J Cardiol       Date:  2015-11-25       Impact factor: 1.596

7.  The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.

Authors:  José Alberto Navarro-García; Rafael Salguero-Bodes; Laura González-Lafuente; Laura Martín-Nunes; Elena Rodríguez-Sánchez; Teresa Bada-Bosch; Eduardo Hernández; Evangelina Mérida-Herrero; Manuel Praga; Jorge Solís; Fernando Arribas; Héctor Bueno; Makoto Kuro-O; María Fernández-Velasco; Luis Miguel Ruilope; Carmen Delgado; Gema Ruiz-Hurtado
Journal:  BMC Med       Date:  2022-01-19       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.